A global platform advancing pharmaceutical collaboration, innovation, and exports—powering healthcare and connecting markets worldwide
The scheme aims to avoid disruption in supply of critical active pharmaceutical ingredients (APIs) used to make critical drugs
Scores highest PAT of Rs. 118 crore in FY25
The National IP Awards recognize outstanding contributions to India’s innovation economy through effective IP creation and commercialization
This marks a significant milestone in Morepen’s strategic entry into one of the world’s largest pharmaceutical markets
Company expects to begin building four more domestic manufacturing sites this year and add 13,000 high-wage manufacturing and construction jobs in America
Mehta is an industry veteran with over 25 years of experience in the pharmaceutical industry
Revenue from Operations for Q3 FY25 was Rs. 454.33 crore,
The Union Budget 2025-26 strengthens India's healthcare sector with an allocation of Rs. 99,858.56 crore, marking a 9.78% rise from Rs. 90,958.63 crore in 2024-25
Q3 FY25 revenue up 24% to Rs 3,230 crore
Subscribe To Our Newsletter & Stay Updated
